Welcome to the UCSF Immunoprofiler.
The mission of the UCSF Immunoprofiler is to develop a translational platform to enhance treatment efficacy, develop precision medicines, and understand the immunological basis for cancer.
We propose that cancers are ultimately discrete forms of immunopathology. By understanding the nature of the immune response, we will determine how to treat cancers and provide new targets for the next round of immunotherapies.
Find out more about us and how you can help.
New 'Immunoprofiler' Initiative will advance drug discovery, precision immunotherapy for cancer (UCSF News Center)
January 19, 2017
UCSF Immunoprofiler begins to profile breast cancers and sarcomas.
January 4, 2017
UCSF Immunoprofiler begins to profile prostate cancers.
December 16, 2017
Abbvie officially joins the UCSF Immunoprofiler consortium.
October 11, 2016
August 15, 2016
August 8, 2016